Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_assertion type Assertion NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_head.
- NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_assertion description "[In contrast, EGFR expression was significantly lower in type II compared with type I EC (34 vs 46%, P=0.041).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_provenance.
- NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_assertion evidence source_evidence_literature NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_provenance.
- NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_assertion SIO_000772 19088718 NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_provenance.
- NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_assertion wasDerivedFrom befree-20140225 NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_provenance.
- NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_assertion wasGeneratedBy ECO_0000203 NP287239.RAflO2SkdAW2tJ0biMI3PsdMCEuRpm1cPKvSTRwnXDK2Y130_provenance.